Beougher v. Regenerative Medicine International LLC

CourtDistrict Court, D. Arizona
DecidedAugust 1, 2023
Docket2:22-cv-01930
StatusUnknown

This text of Beougher v. Regenerative Medicine International LLC (Beougher v. Regenerative Medicine International LLC) is published on Counsel Stack Legal Research, covering District Court, D. Arizona primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Beougher v. Regenerative Medicine International LLC, (D. Ariz. 2023).

Opinion

1 WO 2 3 4 5 6 IN THE UNITED STATES DISTRICT COURT 7 FOR THE DISTRICT OF ARIZONA 8

Gerald B eougher, ) No. CV-22-01930-PHX-SPL ) 9 ) 10 Plaintiff, ) ORDER vs. ) ) 11 ) Regenerative Medicine International ) 12 LLC, et al., ) 13 ) ) 14 Defendants. )

15 Before the Court are a Motion to Dismiss for Lack of Personal Jurisdiction; or, in 16 the Alternative, Motion to Transfer filed by Defendant Regenerative Medicine 17 International, LLC (Doc. 26); a Motion to Dismiss for Lack of Personal Jurisdiction, or in 18 the Alternative Motion to Transfer Venue and Motion to Dismiss for Failure to State 19 Cause of Action filed by Defendants Dr. C. Randall Harrell, Marissa Harrell, 20 Regenerative Processing Plant, LLC, and Regener-Eyes, LLC (Doc. 28); and a Motion to 21 Strike filed by Plaintiff Gerald Beougher (Doc. 44). The Court rules as follows.1 22 I. BACKGROUND 23 Plaintiff Gerald Beougher is an Arizona resident. (Doc. 1 at 1). Defendants Dr. C. 24 Randall Harrell and Marissa Harrell (collectively, “the Harrells”) are a married couple 25 residing in Florida. (Doc. 24 at 2). Defendant Regenerative Medicine International 26

27 1 Because it would not assist in resolution of the instant issues, the Court finds the pending motions are suitable for decision without oral argument. See LRCiv 7.2(f); Fed. 28 R. Civ. P. 78(b); Partridge v. Reich, 141 F.3d 920, 926 (9th Cir. 1998). 1 (“RMI”) is a Florida LLC, with Ms. Harrell as its sole member and Dr. Harrell as its 2 Chief Executive Officer (“CEO”). (Doc. 24 at 1–2). Defendant Regenerative Processing 3 Plant (“RPP”) is a Florida LLC, with Ms. Harrell as a manager and Dr. Harrell as a 4 member. (Doc. 24 at 2). Defendant Regener-Eyes is a Florida LLC, with the Harrells as 5 members and/or managers. (Doc. 24 at 2). 6 Sometime before January 2014, the Harrells hired a licensed brokerage firm to 7 solicit investors for RMI. (Doc. 24 at 3). The firm prepared a memorandum for 8 distribution to potential investors with information about “a natural collagen dermal 9 filler,” Humallagen, “purportedly invented by Dr. Harrell.” (Doc. 24 at 3). In February 10 2014, Plaintiff contacted the firm in response to the memorandum and was referred to Dr. 11 Harrell. (Doc. 24 at 5). Plaintiff alleges that the memorandum, as well as other 12 information later provided by RMI and Dr. Harrell, contained a variety of 13 misrepresentations about RMI. (Doc. 24 at 6). 14 After discussions between Plaintiff and Dr. Harrell, on March 5, 2014, Plaintiff 15 and RMI entered into two contracts. (Doc. 24 at 5–7). First, Plaintiff and RMI executed a 16 Promissory Note in which Plaintiff agreed to loan $500,000 to RMI, with RMI making 17 quarterly interest payments until a final balloon payment due March 5, 2019. (Doc. 24 at 18 7). Plaintiff and RMI also executed an independent contractor agreement (the “Contractor 19 Agreement”) in which Plaintiff agreed to serve as RMI’s Chief Operating Officer 20 (“COO”) and provide consulting services in exchange for $16,666.67 per month. (Doc. 4 21 at 7–8). The Contractor Agreement provided that Plaintiff would “be available as 22 reasonably required through telephone conferences, at his offices in Scottsdale, Arizona 23 and correspondence.” (Doc. 24 at 8). 24 In the following months, pursuant to the Contractor Agreement, Plaintiff 25 performed a variety of work for RMI in Arizona. (Doc. 24 at 10). Nonetheless, RMI 26 never paid Plaintiff the full amount due to him under the Contractor Agreement, instead 27 paying him only half as much monthly. (Doc. 24 at 9–10). In July 2015, a separate 28 dispute arose between Plaintiff, Dr. Harrell, and RMI. (Doc. 24 at 12–13). The parties 1 terminated the Contractor Agreement, and although RMI continued making some 2 payments to Plaintiff in Arizona under the Promissory Note, Plaintiff alleges that he has 3 not been paid in full. (Doc. 24 at 13). 4 On June 13, 2019, Plaintiff filed a Complaint against RMI only in Maricopa 5 County Superior Court alleging breach of contract and breach of the implied covenant of 6 good faith and fair dealing. (Doc. 1 at 2). The case was soon stayed for more than two 7 years pending RMI’s bankruptcy proceedings in Florida. (Doc. 1 at 2). After the stay was 8 lifted, on July 18, 2022, the Maricopa County Superior Court denied RMI’s Rule 9 12(b)(2), (3), and (6) Motion to Dismiss or, in the Alternative, to Transfer Venue. (Doc. 10 35 at 58–59). On October 12, 2022, Plaintiff filed a First Amended Complaint in Superior 11 Court, for the first time naming RPP, Regener-Eyes, and the Harrells as Defendants. 12 (Doc. 1-2). On November 11, 2022, the newly named Defendants removed the case to 13 this Court. (Doc. 1). 14 On January 11, 2023, Plaintiff filed the operative Second Amended Complaint 15 (“SAC”) alleging eight counts: (1) breach of the Promissory Note against RMI and the 16 Harrells; (2) breach of the Promissory Note’s implied covenant of good faith and fair 17 dealing against RMI and the Harrells; (3) breach of the Contractor Agreement against 18 RMI and the Harrells; (4) breach of the Contractor Agreement’s implied covenant of 19 good faith and fair dealing against the Harrells; (5) negligent misrepresentation against 20 RMI and the Harrells; (6) fraudulent inducement against RMI and the Harrells; (7) breach 21 of fiduciary duty against the Harrells; and (8) unjust enrichment against RPP, Regener- 22 Eyes, and the Harrells. (Doc. 26). On March 17, 2023, Plaintiff voluntarily dismissed the 23 breach of fiduciary duty claim. (Doc. 36). 24 On January 25, 2023, RMI filed its pending Motion to Dismiss for Lack of 25 Personal Jurisdiction; or, in the Alternative, Motion to Transfer, which has been fully 26 briefed. (Docs. 26, 35, 38). On January 31, 2023, the other Defendants filed their pending 27 Motion to Dismiss for Lack of Personal Jurisdiction, or in the Alternative Motion to 28 Transfer Venue and Motion to Dismiss for Failure to State Cause of Action, which has 1 been fully briefed. (Docs. 28, 37, 43). On April 25, 2023, Plaintiff filed his pending 2 Motion to Strike, which has been fully briefed. (Docs. 44–46). 3 II. PERSONAL JURISDICTION 4 Because Defendants’ Motions to Transfer are brought in the alternative, the Court 5 first addresses the Motions to Dismiss for Lack of Personal Jurisdiction. 6 a. LEGAL STANDARD 7 Federal Rule of Civil Procedure (“Rule”) 12(b)(2) authorizes dismissal for lack of 8 personal jurisdiction. When a defendant moves to dismiss for lack of personal 9 jurisdiction, “the plaintiff bears the burden of demonstrating that jurisdiction is 10 appropriate.” Schwarzenegger v. Fred Martin Motor Co., 374 F.3d 797, 800 (9th Cir. 11 2004). When the motion is based on written materials rather than an evidentiary hearing, 12 as here, the Court must determine “whether the plaintiff’s pleadings and affidavits make a 13 prima facie showing of personal jurisdiction.” Id. (citation, quotation marks, and 14 alteration omitted). A plaintiff “cannot ‘simply rest on the bare allegations of its 15 complaint,’” but “uncontroverted allegations in the complaint must be taken as true.” Id. 16 (citation omitted). 17 b. DISCUSSION 18 When no federal statute is applicable to govern personal jurisdiction, as is the case 19 here, “the district court applies the law of the state in which the district court sits.” Id. 20 “Arizona’s long-arm jurisdictional statute is co-extensive with federal due process 21 requirements; therefore, the analysis of personal jurisdiction under Arizona law and 22 federal due process is the same.” Biliack v. Paul Revere Life Ins. Co., 265 F. Supp. 3d 23 1003, 1007 (D. Ariz. 2017).

Free access — add to your briefcase to read the full text and ask questions with AI

Related

International Shoe Co. v. Washington
326 U.S. 310 (Supreme Court, 1945)
Burger King Corp. v. Rudzewicz
471 U.S. 462 (Supreme Court, 1985)
Keams v. Tempe Technical Institute, Inc.
993 F. Supp. 714 (D. Arizona, 1997)
Warfield v. Gardner
346 F. Supp. 2d 1033 (D. Arizona, 2004)
Bernard Picot v. Dean Weston
780 F.3d 1206 (Ninth Circuit, 2015)
Loredana Ranza v. Nike, Inc.
793 F.3d 1059 (Ninth Circuit, 2015)
Roberto Silva-Pereira v. Loretta E. Lynch
827 F.3d 1176 (Ninth Circuit, 2016)
Ray Askins v. Usdhs
899 F.3d 1035 (Ninth Circuit, 2018)
Boon Global Limited v. Usdc-Caoak
923 F.3d 643 (Ninth Circuit, 2019)
Ford Motor Co. v. Montana Eighth Judicial Dist.
592 U.S. 351 (Supreme Court, 2021)
Jones v. GNC Franchising, Inc.
211 F.3d 495 (Ninth Circuit, 2000)
Rubio v. Monsanto Co.
181 F. Supp. 3d 746 (C.D. California, 2016)
District Title v. Warren
265 F. Supp. 3d 17 (D.C. Circuit, 2017)
Schwarzenegger v. Fred Martin Motor Co.
374 F.3d 797 (Ninth Circuit, 2004)
Matt Yamashita v. Lg Chem, Ltd.
62 F.4th 496 (Ninth Circuit, 2023)
Roger Silk v. Baron Bond
65 F.4th 445 (Ninth Circuit, 2023)
Erica Davis v. Cranfield Aerospace Solutions
71 F.4th 1154 (Ninth Circuit, 2023)

Cite This Page — Counsel Stack

Bluebook (online)
Beougher v. Regenerative Medicine International LLC, Counsel Stack Legal Research, https://law.counselstack.com/opinion/beougher-v-regenerative-medicine-international-llc-azd-2023.